
Concert Pharmaceuticals

Mr. Richard H. Aldrich M.B.A., Mba (Co-Founder & Independent Chairman)
Dr. Roger D. Tung Ph.D. (Co-Founder, CEO, Pres & Exec. Director)
Mr. Marc A. Becker (Chief Financial Officer)
Summary
History
Concert Pharmaceuticals was founded in 2006 under the leadership of Roger Tung, Ph.D., biopharmaceutical veteran. The company has developed a proprietary platform to identify and develop novel small molecule drugs by utilizing advanced DMPK, medicinal and computational chemistry, and optimizes drug development candidates for improved safety, efficacy and dosing relative to marketed drugs.
Mission
Vision
Key Team
Ms. Nancy Stuart (Chief Operating Officer)
Ms. Justine E. Koenigsberg (Sr. VP of Corp. Communications & Investor Relations)
Mr. Jeffrey A. Munsie (Chief Legal Officer & Corp. Sec.)
Dr. Nabil Uddin Pharm.D. (VP of Corp. Devel.)
Ms. Christine Boisclair (Sr. VP of Regulatory Affairs & Quality Assurance)
Dr. James V. Cassella Ph.D. (Chief Devel. Officer)
Recognition and Awards
References
Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Mr. Richard H. Aldrich M.B.A., Mba (Co-Founder & Independent Chairman)
Dr. Roger D. Tung Ph.D. (Co-Founder, CEO, Pres & Exec. Director)
Mr. Marc A. Becker (Chief Financial Officer)
